05/09/2024 9:12 AM | EyePoint Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 3:23 PM | Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2024 8:25 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 4:08 PM | Adage Capital Management, L.P. (Filed by) EyePoint Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024 7:53 PM | Adage Capital Management, L.P. (Filed by) EyePoint Pharmaceuticals (Subject)
| Form SC 13G | |
04/22/2024 3:15 PM | Adage Capital Management, L.P. (Reporting) Atchinson Robert (Reporting) EyePoint Pharmaceuticals (Issuer) Gross Phillip (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
|
04/02/2024 4:27 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 12:53 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2024 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 4:37 PM | EyePoint Pharmaceuticals (Issuer) Ribeiro Ramiro (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/04/2024 4:40 PM | EyePoint Pharmaceuticals (Issuer) Ribeiro Ramiro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:01 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:08 PM | EyePoint Pharmaceuticals (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024 4:37 PM | Duker Jay S. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:38 PM | Elston George (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:38 PM | EyePoint Pharmaceuticals (Issuer) Jones David Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:39 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:40 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 11:00 AM | EyePoint Pharmaceuticals (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:54 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) EyePoint Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024 9:55 AM | EyePoint Pharmaceuticals (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
02/05/2024 4:15 PM | EyePoint Pharmaceuticals (Issuer) Jones David Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:22 PM | EyePoint Pharmaceuticals (Subject) Jones David Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 3:53 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:51 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:54 PM | EyePoint Pharmaceuticals (Issuer) Jones David Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:24 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:26 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:50 PM | EyePoint Pharmaceuticals (Issuer) Jones David Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 3:25 PM | EyePoint Pharmaceuticals (Subject) Lurker Nancy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 3:42 PM | EyePoint Pharmaceuticals (Subject) Lurker Nancy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 3:19 PM | EyePoint Pharmaceuticals (Subject) Paggiarino Dario A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 3:19 PM | EyePoint Pharmaceuticals (Subject) Jones David Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 5:55 PM | EyePoint Pharmaceuticals (Issuer) Ocumension Therapeutics (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:01 PM | EyePoint Pharmaceuticals (Issuer) Liu Ye (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 4:33 PM | EyePoint Pharmaceuticals (Subject) Ocumension Therapeutics (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:53 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 8:28 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:17 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon Musk Secret Crypto Plot Exposed (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
01/09/2024 7:53 PM | ADAMIS ANTHONY P (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:53 PM | ANDO GORAN (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:54 PM | DICICCO WENDY F (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:54 PM | Duty Stuart (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:55 PM | EyePoint Pharmaceuticals (Issuer) Landis John B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:56 PM | EyePoint Pharmaceuticals (Issuer) GUYER DAVID R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:04 PM | Elston George (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:07 PM | Duker Jay S. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:09 PM | EyePoint Pharmaceuticals (Issuer) Jones David Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:11 PM | EyePoint Pharmaceuticals (Issuer) Pine Michael Craig (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 8:12 PM | EyePoint Pharmaceuticals (Issuer) Zaderej Karen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 5:37 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4/A | |
01/02/2024 4:41 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 4:14 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:52 PM | Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 4:28 PM | EW Healthcare Partners, L.P. (Filed by) EyePoint Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/07/2023 8:21 PM | EyePoint Pharmaceuticals (Issuer) Ocumension Therapeutics (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 8:03 PM | EyePoint Pharmaceuticals (Issuer) Liu Ye (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 5:11 AM | EyePoint Pharmaceuticals (Filer)
| Form 424B5 | |
12/06/2023 4:18 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:19 PM | EyePoint Pharmaceuticals (Issuer) Paggiarino Dario A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 4:20 PM | EyePoint Pharmaceuticals (Issuer) Pine Michael Craig (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:39 PM | Chen Bihua (Reporting) Cormorant Asset Management, LP (Reporting) Cormorant Global Healthcare Master Fund, LP (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 7:54 AM | EyePoint Pharmaceuticals (Subject) Ocumension Therapeutics (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 4:31 PM | EyePoint Pharmaceuticals (Filer)
| Form 424B5 | |
12/04/2023 3:34 PM | EyePoint Pharmaceuticals (Subject) Lurker Nancy (Reporting)
| Form 144/A | |
12/04/2023 3:15 PM | EyePoint Pharmaceuticals (Subject) Pine Michael Craig (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 3:16 PM | EyePoint Pharmaceuticals (Subject) Paggiarino Dario A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 2:39 PM | EyePoint Pharmaceuticals (Subject) Lurker Nancy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:00 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 2:47 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 11:15 PM | EyePoint Pharmaceuticals (Filer)
| Form EFFECT | |
10/20/2023 4:15 PM | EyePoint Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/20/2023 4:18 PM | EyePoint Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/17/2023 3:47 PM | Elston George (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:48 PM | Duty Stuart (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/17/2023 3:49 PM | Duty Stuart (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 6:06 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 10:15 AM | EyePoint Pharmaceuticals (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
09/11/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2023 6:10 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4/A | |
09/01/2023 3:51 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 4:46 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 4:22 PM | EW Healthcare Partners, L.P. (Filed by) EyePoint Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/30/2023 4:32 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4/A | |
08/28/2023 5:32 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/24/2023 4:30 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting) Essex Woodlands IX, LLC (Reporting) EW Healthcare Partners, L.P. (Reporting) EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
08/22/2023 3:23 PM | EW Healthcare Partners-A, L.P. (Reporting) EyePoint Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023 3:17 PM | EW Healthcare Partners, L.P. (Reporting) EyePoint Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2023 2:09 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2023 5:51 PM | EyePoint Pharmaceuticals (Issuer) Zaderej Karen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 5:52 PM | EyePoint Pharmaceuticals (Issuer) Lurker Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2023 5:53 PM | Duker Jay S. (Reporting) EyePoint Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2023 6:06 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |